These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20809843)

  • 1. Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data.
    McNeil MM; Broder KR; Vellozzi C; DeStefano F
    Clin Infect Dis; 2010 Oct; 51(7):871-2; author reply 872-3. PubMed ID: 20809843
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of fatal adverse events after H1N1 influenza vaccination.
    Nakada H; Narimatsu H; Tsubokura M; Murashige N; Matsumura T; Kodama Y; Kishi Y; Kami M
    Clin Infect Dis; 2010 Jun; 50(11):1548-9. PubMed ID: 20433361
    [No Abstract]   [Full Text] [Related]  

  • 3. Informal network of communication tools played an important role in sharing safety information on H1N1 influenza vaccine.
    Nakada H; Murashige N; Matsumura T; Kodama Y; Kami M
    Clin Infect Dis; 2010 Oct; 51(7):873-4. PubMed ID: 20809846
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
    Härmark L; van Hunsel F; Hak E; van Grootheest K
    Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM
    Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-licensure safety surveillance for influenza A(H1N1) pandemic vaccines: first results].
    Jacquet A; Ouaret S; Kreft-Jaïs C; Castot A
    Rev Prat; 2010 Dec; 60(10):1392-4. PubMed ID: 21425536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse events after administration of A/H1N1 vaccine to patients].
    Hernández-García I; Haro-Pérez AM; González-Celador R; Sáenz-González Mdel C
    Med Clin (Barc); 2011 Jun; 137(3):136-7. PubMed ID: 20199781
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.
    Souza AR; Braga JA; de Paiva TM; Loggetto SR; Azevedo RS; Weckx LY
    Vaccine; 2010 Jan; 28(4):1117-20. PubMed ID: 20116631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.
    Committee on Infectious Diseases
    Pediatrics; 2009 Oct; 124(4):1216-26. PubMed ID: 19736264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial.
    Oh CE; Lee J; Kang JH; Hong YJ; Kim YK; Cheong HJ; Ahn YJ; Kim SH; Lee HJ
    Vaccine; 2010 Aug; 28(36):5857-63. PubMed ID: 20600483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina.
    Orellano PW; Reynoso JI; Carlino O; Uez O
    Vaccine; 2010 Jul; 28(32):5288-91. PubMed ID: 20541580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
    N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.